Penumbra Inc (PEN)
Health Care / Health Care Equipment
S&P MidCap 400$328.99
Middle of the pack. No strong signal either way.
Consider Buy
Score based on 3 of 5 models — moderate confidence
Is Penumbra Inc a Good Investment in 2026?
Penumbra Inc (PEN) scores 6.3 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Piotroski model rates Penumbra Inc as Attractive (6/9). However, the Graham model rates it Caution — Significantly above fair value. Penumbra Inc ranks #221 out of 1127 stocks in the Health Care sector.
This summary is algorithmically generated and is not financial advice.
Key Metrics
Valuation
Trades at 73x earnings — above sector median of 25x.
Fair value estimate not available for this stock.
5-Model Analysis
Each model evaluates this stock from a different angle. Combined, they form the composite score above.
Piotroski
Attractive
6/9
Buffett
Attractive
Business quality & competitive moat
Graham
Caution
Significantly above fair value
Lynch
Limited Data
Growth rate vs price (PEG)
Greenblatt
Limited Data
Earnings yield + return on capital
Frequently Asked Questions
Is Penumbra Inc (PEN) a good investment?
What is Penumbra Inc's Piotroski F-Score?
Is PEN overvalued or undervalued?
How does PEN compare to other Health Care stocks?
What do investment models say about PEN?
Similar Stocks
Compare PEN with
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer